Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Antony, Sherin ^a   Kumar T , Peeyush ^a   Mathew, Jobin ^a   Anju, T R ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUNGAROTOXIN RECEPTOR; CHOLINERGIC RECEPTOR; GLUCOSE TRANSPORTER 3; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CEREBELLUM DISEASE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; STREPTOZOCIN DIABETES; ANIMAL; DOWN REGULATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; UPREGULATION; WISTAR RAT;

RATTUS;

ANIMALS; BLOOD GLUCOSE; CEREBELLUM; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 3; HYPOGLYCEMIA; MALE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; UP-REGULATION;

EID: 77950282963     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-7     Document Type: Article

References (62)

1. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. S Pramming B Thorsteinsson I Bendtson C Binder, Diabet Med 1991 8 217 222 10.1111/j.1464-5491.1991.tb01575.x 1828735
2. Adaption in brain glucose uptake following recurrent hypoglycemia. NR Boyle A O' Connor S Kempers R Yeo C Qualis, Proc Acad Sci USA 1994 91 9352 9356 10.1073/pnas.91.20.9352
3. Hypoglycemic neuronal death and cognitive impairment are prevented by poly (ADP-ribose) polymerase inhibitors administered after hypoglycemia. SW Suh K Aoyama Y Chen P Garnier Y Matsumori E Gum J Liu RA Swanson, J Neurosci 2003 23 10681 10690 14627653
4. Zinc release contributes to hypoglycemia-induced neuronal death. SW Suh P Garnier K Aoyama Y Chen RA Swanson, Neurobiol Dis 2004 16 538 545 10.1016/j.nbd.2004.04.017 15262265
5. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. SW Suh K Aoyama Y Matsumori J Liu RA Swanson, Diabetes 2005 54 1452 1458 10.2337/diabetes.54.5.1452 15855333
6. Hypoglycemic brain injury. RC Vannucci SJ Vannucci, Semin Neonatol 2001 6 147 155 10.1053/siny.2001.0044 11483020
7. Role of excitatory aminoacids in neonatal hypoglycemia. YZ Aral K Gucuyener Y Atalay A Hasanoglu C Turkyilmaz A Sayal G Biberoglu, Acta Paediatr Jpn 1998 40 303 306 9745769
8. Excitotoxic mechanisms and age-related susceptibility to brain damage in ischemia, hypoglycemia and toxic mussel poisoning. RN Auer, Neurotoxicol 1991 12 541 546
9. Hypoglycaemia: brain neurochemistry and neuropathology. RN Auer BK Siesjo, Baillieres Clin Endocrinol Metab 1993 7 611 625 10.1016/S0950-351X(05) 80210-1 8379907
10. New Evidence of Cerebellar and Brainstem Hypoplasia in Autistic Infants, Children and Adolescents: The MR Imaging Study by Hashimoto and Colleagues. E Courchesne, J Autism Dev Disord 1995 25 19 22 10.1007/BF02178164 7608031
11. A severe frontal-parietal lobe syndrome following cerebellar damage. TC Botez-Marquard J Bard MI Léveillé Botez, Eur J of Neurol 2001 8 347 353 10.1046/j.1468-1331.2001.00204.x (Pubitemid 32612898)
12. Cognition, emotion and the cerebellum Brain. JD Schmahmann David Caplan, 2006 129 290 292 16434422
13. Clinical spectrum associated with cerebellar hypoplasia. E Wassmer Paul Davies P William Whitehouse H Stuart Green, Pediatr Neurol 2003 28 347 351 10.1016/S0887-8994(03)00016-X 12878295
14. The enhancing effects of hippocampal infusions of glucose are not restricted to spatial working memory. DL Krebs MB Parent, Neurobiol Learn Mem 2005 83 168 172 10.1016/j.nlm.2004.10.004 15721802
15. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. EC McNay M Thomas E Fries Paul Gold, Proc Natl Acad Sci USA 2000 97 2881 2885 10.1073/pnas.050583697 10706633
16. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. LA Volpicelli AI Levey, Prog Brain Res 2004 145 59 66 14650906
17. Release of [3H]-L-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices. LA Reno W Zago RP Markus, Neurosci 2004 647 653 10.1016/j.neuroscience.2003.12.023 (Pubitemid 38251330)
18. Evidence for nicotinic acetylcholine receptor activation in rat cerebellar slices. G De Filippi T Baldwinson E Sher, Pharmacol Biochem Behav 2001 70 447 455 10.1016/S0091-3057(01)00653-0 11796144
19. Multiple modes of GABAergic inhibition of rat cerebellar granule cells. DJ Rossi M Hamann D Attwell, J Physiol 2003 548 97 110 10.1113/jphysiol.2002. 036459 12588900
20. Developmental regulation of nicotinic acetylcholine receptormediated [3H] norepinephrine release from rat cerebellum. KT O'Leary FM Leslie, J Neurochem 2003 84 952 959 10.1046/j.1471-4159.2003.01575.x 12603820
21. Dopamine, norepinephrine and serotonin in the brain of diabetic rats and man. Z Lackovic M Salkovic Z Kuci M Relja, Journal of Neurochemistry 1985 44 94 98 10.1111/j.1471-4159.1985.tb07117.x 3964838
22. Diabetes induced alterations in brain monoamine metabolism in rats. M Bitar M Koulu SI Rapoport M Linnoila, Journal of Pharmacology and Experimental Therapeutics 1986 236 432 437 2418197
23. Dopaminergic activity is reduced in diabetic rats. CF Saller, Neuroscience Letters 1984 49 301 306 10.1016/0304-3940(84)90306-9 6493613
24. Classification of muscarinic acetylcholine receptors. MP Caulfield NJM Birdsall, Pharmacol Rev 1998 50 279 290 9647869
25. The concentrations of dopamine 5 Hydroxytryptamine and some of their acid metabolites in the brain of genetically diabetic rats. RPS Kwok EK Walls AV Juoria, Neurochemical Research 1985 10 611 616 10.1007/BF00964400 2409457
26. Effects of short and long-lasting diabetes mellitus on mouse brain monoamines. CC Chen JC Yang, Brain Research 1991 552 175 179 10.1016/0006-8993(91)90677-N 1913176
27. Brain catecholamine concentrations in hyperosmolar diabetic and diabetic rats. Y Tasaka H Matsumoto Y Inove Y Hirata, Diabetes Research 1992 19 1 7 1468182
28. Decreased muscarinic M1 receptor gene expression in the hypothalamus, brainstem, and pancreatic islets of streptozotocin-induced diabetic rats. G Gireesh SB Kaimal TP Kumar CS Paulose, J Neurosci Res 2007 86 947 953 10.1002/jnr.21544
29. Decreased muscarinic M1 receptor gene expression in the cerebral cortex of streptozotocin-induced diabetic rats and Aegle marmelose leaf extract's therapeutic function. G Gireesh SK Reas M Jobin CS Paulose, J Ethnopharmacol 2007 116 296 304 10.1016/j.jep.2007.11.036 18201849
30. Acute hypoglycemia impairs the functioning of the central but not peripheral nervous system. MWJ Strachan JD Ian ME Fiona SC Ewinga Stewart JY Fergusona Matthew MF Brian, Physiol Behav 2001 72 83 92 10.1016/S0031-9384(00) 00380-2 11239984
31. Hypoglycemia-induced cerebellar dysfunction and quantitative positron emission tomography study. DE Kim SH Park SK Kim HW Nam YS Lee JK Chung JK Roh, Neurol 2000 55 418 422
32. Enhanced [3H] Glutamate Binding in the Cerebellum of Insulin-Induced Hypoglycaemic and Streptozotocin-Induced Diabetic Rats. A Joseph R Remya CS Paulose, Cell Mol Neurobiol 2007 27 1085 1095 10.1007/s10571-007-9198-1 17805958
33. Increased Glutamate Receptor Gene Expression In The Cerebral Cortex Of Insulin Induced Hypoglycemic And Streptozotocin-Induced Diabetic Rats. A Joseph S Antony CS Paulose, Neuroscience 2008 156 298 304 10.1016/j.neuroscience.2008. 07.022 18761060
34. Kidney function in experimental diabetic ketosis. M Hohenegger B Rudas, Diabetol 1971 7 334 338 10.1007/BF01219467
35. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. RN Arison EI Ciaccio MS Glitzer JA Cassaro MP Pruss, Diabetes 1967 16 51 56 6015682
36. The influence of insulin on circulating ghrelin. DE Flanagan ML Evans TP Monsod F Rife RA Heptulla WV Tamborlane RS Sherwin, Am J Physiol Endocrinol Metab 2003 284 313 E316 12531744
37. Regional studies of catecholamines in the rat brain. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J Glowinski LL Iversen, J Neurochem 1966 13 655 669 10.1111/j.1471-4159. 1966.tb09873.x 5950056
38. 3H] QNB in rat brain. HI Yamamura G Synder, Proc Natl Acad Sci USA 1981 71 1725 1729 10.1073/pnas.71.5.1725
39. New and rapid colorimetric determination of acetylcholinesterase activity. GL Ellman KD Courteney V Andres RMA Featherstone, Biochem Pharmacol 1961 7 88 95 10.1016/0006-2952(61)90145-9 13726518
40. Protein measurement with Folin phenol reagent. OH Lowry N Roserbbrough AL Farr RJ Randall, J Biol Chem 1951 193 265 275 14907713
41. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. Z Lackovic M Salkovic Z Kuci M Relja, J Neurochem 1990 541 43 147
42. Protection by lactate of cerebral function during hypoglycaemia. A Maran I Cranston J Lomas I Macdonald SA Amiel, Lancet 1994 343 16 20 10.1016/S0140-6736(94)90876-1 7905041
43. Behavioural aspects of cerebellar function in adults with Asperger syndrome. E Gowen C Miall, Cerebellum 2005 4 1 11 10.1080/14734220500355332 (Pubitemid 43861189)
44. Human cerebellar activity reflecting an acquired internal model of a new tool. H Imazumi S Miyauchi T Tamada Y Sasaki R Takino B Putz T Yoshioka M Kawato, Nature 2000 3 192 195
45. Disturbances of motor preparation in basal ganglia and cerebellar disorders. H Diener J Dichgans B Guschlbauer M Bacher P Langenbach, Prog Brain Res 1989 80 481 488 2634284
46. Attentional activation of the cerebellum independent of motor involvement. G Allen RB Buxton EC Wong E Courchesne, Science 1997 275 1940 1943 10.1126/science.275.5308.1940 9072973
47. Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats. JF Marchall MI Friedman TG Heffner, Brain Res 1976 111 428 432 10.1016/0006-8993(76)90789-7 949615
48. Treating depression in diabetic patients, is there an alternative to medications. AM Jacobson K Weinger, Ann Intern Med 1998 129 656 657 9786815
49. Cognition and synaptic plasticity in diabetes mellitus. WH Gispen GJ Biessels, Trends in Neurosci 2000 23 542 549 10.1016/S0166-2236(00)01656-8
50. BE Levin VH Routh L Kang NM Sanders AA Dunn Meynell, Diabetes 2004 53 2521 2528 10.2337/diabetes.53.10.2521 15448079
51. Glucose prevents glutathione oxidation and mitochondrial damage after glutamate receptor stimulation in rat cortical primary neurons. M Delgado Esteban A Almeida JP Bolanos, J Neurochem 2000 75 1618 1624 10.1046/j.1471-4159. 2000.0751618.x 10987843
52. The impact of diabetes on the CNS. AL McCall, Diabetes 1992 41 557 570 10.2337/diabetes.41.5.557 1568525
53. The glucose transporter - family, structure, function and tissue-specific expression. GW Gould GD Holman, Biochem J 1993 295 295 329 8216231
54. Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation. M Kim Yu Zhao-Xue BF Bertil R Scott, Am J Physiol Endocrinol Metab 2005 289 562 E569 10.1152/ajpendo.00112.2005 16150954
55. Glucose Transport and Glucose Homeostasis: New Insights from Transgenic Mice. MM Mueckler, News Physiol Sci 1995 10 22 29
56. Time dependent alterations of cholinergic markers after experimental traumatic brain injury. CK Donat MU Schuhmann C Voigt K Nieber W Deuther-Conrad P Brust, Brain Res 2008 1246 167 177 10.1016/j.brainres.2008.09.059 18848922
57. Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice. N Kuczewski A Eugenio G Dinesh Wess Jürgen D Luciano, J Physiol 2005 566 907 919 10.1113/jphysiol.2005.089987 15919709
58. Regional acetylcholine metabolism in brain during acute hypoglycemia and recovery. JB Ghajar GE Gibson TE Duffy, J Neurochem 1985 44 94 98 10.1111/j.1471-4159.1985.tb07117.x 3964838
59. Hypoglycaemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. SW Sang ET Gum AM Hamby PH Chan RA Swanson, J Clin Invest 2007 117 910 918 10.1172/JCI30077 17404617
60. Enhanced NMDAR1, NMDA2B and mGluR5 Receptors Gene Expression In The Cerebellum Of Insulin Induced Hypoglycaemic And Streptozotocin Induced Diabetic Rats. Anu Joseph Peeyush Kumar T MS Nandhu CS Paulose, Eur J of Pharmacol 2010
61. Effect of succinylcholine on the neuromuscular junction of hypoglycemic rats. O Thomareis A Parlapani L Kovatsi M Giala, Methods Find Exp Clin Pharmacol 2000 22 155 158 10893697
62. Hypoglycemia and seizures in large full-term neonates. MJ Gordon, AAP Grand Rounds 2006 16 43 44